Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.
Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.
The presence of malignant lymph nodes (+ypNodes) in the surgical specimen after preoperative chemoradiation (trimodality) in patients with oesophageal cancer (EC) portends a poor prognosis for overall survival (OS) and disease-free survival (DFS). Currently, none of the clinical variables highly correlates with +ypNodes. We hypothesised that a combination of clinical variables could generate a model that associates with high likelihood of +ypNodes after trimodality in EC patients.
We report on 293 consecutive EC patients who received trimodality therapy. A multivariate logistic regression analysis that included pretreatment and post-chemoradiation variables identified independent variables that were used to construct a nomogram for +ypNodes after trimodality in EC patients.
Of 293 patients, 91 (31.1%) had +ypNodes. OS (p=0.0002) and DFS (p<0.0001) were shorter in patients with +ypNodes compared to those with -ypNodes. In multivariable analysis, the significant variables for +ypNodes were: baseline T-stage (odds ratio [OR], 7.145; 95% confidence interval [CI], 1.381-36.969; p=0.019), baseline N-stage (OR, 2.246; 95% CI, 1.024-4.926; p=0.044), tumour length (OR, 1.178; 95% CI, 1.024-1.357; p=0.022), induction chemotherapy (OR, 0.471; 95% CI, 0.242-0.915; p=0.026), nodal uptake on post-chemoradiation positron emission tomography (OR, 2.923; 95% CI, 1.007-8.485; p=0.049) and enlarged node(s) on post-chemoradiation computerised tomography (OR, 3.465; 95% CI, 1.549-7.753; p=0.002). The nomogram after internal validation using the bootstrap method (200 runs) yielded a high concordance index of 0.756.
Our nomogram highly correlates with the presence of +ypNodes after chemoradiation, however, considerably more refinement is needed before it can be implemented in the clinic.
在接受术前放化疗(三联疗法)的食管癌患者的手术标本中存在恶性淋巴结(+ypNodes),预示着总生存(OS)和无病生存(DFS)的预后不良。目前,没有任何临床变量与+ypNodes 高度相关。我们假设,临床变量的组合可以生成一个模型,该模型与三联疗法后食管癌患者发生+ypNodes 的可能性高度相关。
我们报告了 293 例连续接受三联疗法的食管癌患者。多变量逻辑回归分析包括预处理和放化疗后变量,确定了独立变量,用于构建三联疗法后食管癌患者+ypNodes 的列线图。
在 293 例患者中,91 例(31.1%)存在+ypNodes。与-ypNodes 相比,+ypNodes 患者的 OS(p=0.0002)和 DFS(p<0.0001)更短。多变量分析中,+ypNodes 的显著变量为:基线 T 期(优势比[OR],7.145;95%置信区间[CI],1.381-36.969;p=0.019)、基线 N 期(OR,2.246;95%CI,1.024-4.926;p=0.044)、肿瘤长度(OR,1.178;95%CI,1.024-1.357;p=0.022)、诱导化疗(OR,0.471;95%CI,0.242-0.915;p=0.026)、放化疗后正电子发射断层扫描(PET)的淋巴结摄取(OR,2.923;95%CI,1.007-8.485;p=0.049)和放化疗后计算机断层扫描(CT)的肿大淋巴结(OR,3.465;95%CI,1.549-7.753;p=0.002)。内部验证使用自举法(200 次运行)后生成的列线图具有 0.756 的高一致性指数。
我们的列线图与放化疗后+ypNodes 的存在高度相关,但在临床应用之前还需要进一步细化。